Energy Stress‐Induced Neuroprotection Against Ferroptosis in Dopaminergic Neurons
Journal of Neurochemistry · 2026-06 · 170 (6)
DOI: 10.1111/jnc.70487 ↗At a glance
Journal article in Journal of Neurochemistry, published online on 2026-06-01. Written by Aurélie Jonneaux and 8 co-authors. Institution: Département de Pharmacologie Médicale, Université de Lille, LilNCog-Lille Neuroscience & Cognition, Equipe TREAT, INSERM UMRS_1172, CHU Lille, LICEND…. Major MEDLINE topics: Ferroptosis, Dopaminergic Neurons, Energy Metabolism, Neuroprotection. Cited 1 times so far (Crossref); 15 references. The full text is freely available (open access, CC BY 4.0). Funded by: Crédit Agricole Foundation, Foundation de France, Hauts-de-France Region.
Abstract (original language)
Ferroptosis, an iron‐dependent form of regulated necrosis, is implicated in the pathogenesis of Parkinson's disease (PD). We studied the influence of energy stress on ferroptosis in differentiated dopaminergic neurons (LUHMES). Glucose deprivation conferred protection against ferroptosis induced by erastin or arachidonic acid plus iron by reducing lipid peroxidation. Glucose withdrawal did not protect against RSL3‐induced ferroptosis, suggesting that direct GPX4 inhibition cannot be reversed by metabolic modulation. The expression of ferroptosis markers ACSL4, GPX4, xCT, and TFRc remained unaltered during glucose deprivation. Inhibition of glycolysis using 2‐deoxyglucose confirmed the role of energy stress in the regulation of ferroptosis. Activation of AMP‐activated protein kinase (AMPK) by AICAR protected LUHMES cells from erastin‐induced ferroptosis, even in the presence of glucose. Conversely, AMPK expression inhibition by siRNA re‐sensitized cells to ferroptosis under glucose‐free conditions. These findings suggest that glucose metabolism and AMPK‐mediated energetic stress play crucial roles in regulating ferroptosis in dopaminergic neurons, with potential implications for understanding the mechanisms of neurodegeneration in PD. These findings identify a potential bioenergetic checkpoint regulating ferroptosis susceptibility under conditions of severe energy stress. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Département de Pharmacologie Médicale, Université de Lille, LilNCog-Lille Neuroscience & Cognition, Equipe TREAT, INSERM UMRS_1172, CHU Lille, LICEND COEN Center, Lille, France.
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre le Cancer de Lille, UMR9020-UMR-S 1277-Canther Cancer Heterogeneity, Plasticity and Therapy Resistance, Lille, France.
- Service de Biochimie, Centre de Biologie-Pathologie, CHU Lille, Lille, France.
- Banque de Tissus, Centre de Biologie-Pathologie, CHU Lille, Lille, France.
ORCID profiles: Aurélie Jonneaux, Philippe Marchetti
Funding
- Crédit Agricole Foundation
- Foundation de France
- Hauts-de-France Region
- Lille University
- INSERM
- Institut National de la Santé et de la Recherche Médicale
Cite
APA
Jonneaux, A., Laine, W., Maboudou, P., Kluza, J., Bonte, M. A., Gouel, F., Devos, D., Marchetti, P., & Devedjian, J. C. (2026). Energy Stress‐Induced Neuroprotection Against Ferroptosis in Dopaminergic Neurons. Journal of Neurochemistry, 170(6). https://doi.org/10.1111/jnc.70487
Vancouver
Jonneaux A, Laine W, Maboudou P, Kluza J, Bonte MA, Gouel F, et al. Energy Stress‐Induced Neuroprotection Against Ferroptosis in Dopaminergic Neurons. Journal of Neurochemistry. 2026;170(6). doi:10.1111/jnc.70487
BibTeX
@article{Jonneaux2026,
author = {Jonneaux, Aurélie and Laine, William and Maboudou, Patrice and Kluza, Jérôme and Bonte, Marie-Amandine and Gouel, Flore and Devos, David and Marchetti, Philippe and Devedjian, Jean-Christophe},
title = {Energy Stress‐Induced Neuroprotection Against Ferroptosis in Dopaminergic Neurons},
journal = {Journal of Neurochemistry},
year = {2026},
volume = {170},
number = {6},
doi = {10.1111/jnc.70487}
}
EUVIMED